Estimate Recalculated Nov 1, 2024 10:13AM EST
Matthew Pauls has an estimated net worth of $6.81 Million. This is based on reported shares across multiple companies, which include INSMED Inc, Strongbridge Biopharma plc, Egalet Corp, Savara Inc, and SOLENO THERAPEUTICS INC.
Matthew Pauls's CIK is 0001573429
2021 was Matthew Pauls's most active year for acquiring shares with 13 total transactions. Matthew Pauls's most active month to acquire stocks was the month of November. 2020 was Matthew Pauls's most active year for disposing of shares, totalling 3 transactions. Matthew Pauls's most active month to dispose stocks was the month of November. 2014 saw Matthew Pauls paying a total of $992,100.00 for 60,000 shares, this is the most they've acquired in one year. In 2023 Matthew Pauls cashed out on 212,680 shares for a total of $883,976.40, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!